Medicinal Products Licensing

Dáil Éireann Debate, Wednesday - 6 March 2019

Wednesday, 6 March 2019

Questions (159)

Clare Daly

Question:

159. Deputy Clare Daly asked the Minister for Health if Pembrolizumab has received marketing authorisation here and in the EU, respectively, for the treatment of cervical cancer. [10972/19]

Written answers

Minister for Health

I wish to advise the Deputy that Pembrolizumab does not have a marketing authorisation for the treatment of cervical cancer in Ireland or the EU.